Young Wendy B.insider trades

In SEC Form 4 filings, Young Wendy B. is listed as Director of Rapport Therapeutics, Inc. (RAPP) and Director of Adial Pharmaceuticals, Inc. (ADIL). In the last 90 days, Young Wendy B. bought $100K of Rapport Therapeutics, Inc. (RAPP) on the open market and sold none. The purchase was $100K of Rapport Therapeutics, Inc. (RAPP) on Oct 22. Took part in a cluster buy; the latest at Rapport Therapeutics, Inc. (RAPP), where 6 insiders bought within 3 days, ending Oct 23.

Companies and roles

Company	Role	Transactions	Last filed
RAPPRapport Therapeutics, Inc.	Director	1	Oct 22
ADILAdial Pharmaceuticals, Inc.	Director	1	Sep 21

Cluster buys

RAPP: 6 insiders bought $1.66M between Oct 21 – Oct 23.

Form 4 historysince 2026-09-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RAPPRapport Therapeutics, Inc.	Oct 22	Oct 22	P	3,789	$26.39	Purchase +$99,992	13,289	No	Form 4
ADILAdial Pharmaceuticals, Inc.	Sep 17	Sep 21	A · derivative	25,666	$2.98	$76,485	25,666	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.